| 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach - as a primary procedure code | 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach - as a primary or secondary procedure code | |
|---|---|---|
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | 56,781 | 121,248 |
| Total Medicare Hospitalizations - Jan 2017 to Dec 2017 (Present on Admission - All) | 26,032 | 49,467 |
| Total Medicare Hospitalizations - Jan 2013 to Dec 2017 (Present on Admission - All) | ||
| Total Medicare Hospitalizations after Exclusion | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) |
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 613,072 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 5,062 | ||||
| DRG Share of Total Hospitalizations | 5.62 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 19.45 | ||||
| Avg LOS at DRG | 6.22 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 6.75 | ||||
| Readmission Rate at DRG | 24.07 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 22.5 | ||||
| Unplanned Readmission Rate at DRG | 16.7 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 18.7 | ||||
| Total Medicare payments at DRG | $7,124,851,803 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $72,031,871 | ||||
| Total Medicare payment per Day at DRG | $1,870 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,109 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,622 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $14,230 | ||||
| Total Medicare Charges at DRG | $36,341,515,154 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $264,589,377 | ||||
| Avg Charges at DRG | $59,278 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $52,270 | ||||
| Mortality Rate at DRG | 12.04 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 10.69 | ||||
| SNF Discharge Rate at DRG | 27.01 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 29.34 | ||||
| Home Discharge Rate at DRG | 25.82 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 25.66 |
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 222,943 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 962 | ||||
| DRG Share of Total Hospitalizations | 2.04 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 3.7 | ||||
| Avg LOS at DRG | 4.65 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 4.92 | ||||
| Readmission Rate at DRG | 23.17 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 21.75 | ||||
| Unplanned Readmission Rate at DRG | 18.17 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 18.68 | ||||
| Total Medicare payments at DRG | $1,580,729,714 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $7,577,732 | ||||
| Total Medicare payment per Day at DRG | $1,523 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,601 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,090 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $7,877 | ||||
| Total Medicare Charges at DRG | $8,078,276,720 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $29,225,723 | ||||
| Avg Charges at DRG | $36,235 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $30,380 | ||||
| Mortality Rate at DRG | 1.32 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 1.35 | ||||
| SNF Discharge Rate at DRG | 15.32 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 18.5 | ||||
| Home Discharge Rate at DRG | 51.14 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 48.34 |
| DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 46,671 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 492 | ||||
| DRG Share of Total Hospitalizations | 0.43 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.89 | ||||
| Avg LOS at DRG | 3.05 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 3.39 | ||||
| Readmission Rate at DRG | 10.77 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 8.22 | ||||
| Unplanned Readmission Rate at DRG | 6.8 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 6.39 | ||||
| Total Medicare payments at DRG | $210,061,424 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,832,272 | ||||
| Total Medicare payment per Day at DRG | $1,476 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,700 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,501 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $5,757 | ||||
| Total Medicare Charges at DRG | $904,921,999 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $9,904,842 | ||||
| Avg Charges at DRG | $19,389 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $20,132 | ||||
| Mortality Rate at DRG | 0.63 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | NA | ||||
| SNF Discharge Rate at DRG | 13.08 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 15.24 | ||||
| Home Discharge Rate at DRG | 62.36 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 59.55 |
| DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 29,406 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 271 | ||||
| DRG Share of Total Hospitalizations | 0.27 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.04 | ||||
| Avg LOS at DRG | 6.14 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 6.5 | ||||
| Readmission Rate at DRG | 26.52 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 25.1 | ||||
| Unplanned Readmission Rate at DRG | 18.77 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 19.25 | ||||
| Total Medicare payments at DRG | $278,842,414 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $3,207,614 | ||||
| Total Medicare payment per Day at DRG | $1,545 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,821 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,483 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $11,836 | ||||
| Total Medicare Charges at DRG | $1,274,840,439 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $10,955,882 | ||||
| Avg Charges at DRG | $43,353 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $40,428 | ||||
| Mortality Rate at DRG | 1.86 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | NA | ||||
| SNF Discharge Rate at DRG | 27.52 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 29.89 | ||||
| Home Discharge Rate at DRG | 33.31 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 29.15 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2017 to Dec 2017 ) |
|---|---|---|---|---|---|
| NEW YORK - PRESBYTERIAN/QUEENS | 56-45 MAIN STREET | NEW YORK | NY | 11355 | 1,902 |
| MONTEFIORE MEDICAL CENTER | 111 E 210TH ST | BRONX | NY | 10467 | 1,440 |
| NEWYORK PRESBYTERIAN - WEILL CORNELL MEDICAL CENTER | 525 E 68TH ST | NEW YORK | NY | 10021 | 1,384 |
| THE UNIVERSITY OF TENNESSEE MEDICAL CENTER | 1924 ALCOA HWY | KNOXVILLE | TN | 37920 | |
| CROUSE HOSPITAL | 736 IRVING AVE | SYRACUSE | NY | 13210 | |
| SENTARA RMH MEDICAL CENTER | 2010 HEALTH CAMPUS DR | HARRISONBURG | VA | 22801 | |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | |
| STATEN ISLAND UNIVERSITY HOSPITAL | 475 SEAVIEW AVE | STATEN ISLAND | NY | 10305 | |
| MOUNT SINAI WEST | 1000 10TH AVE | NEW YORK | NY | 10019 | |
| ST. ELIZABETH CAMPUS | 2209 GENESEE ST | UTICA | NY | 13501 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2017 to Dec 2017 ) |
|---|---|---|---|---|---|
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 140 |
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 129 |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 122 |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. FRANCOIS DUFRESNE | 1111 AMSTERDAM AVE | NEW YORK | NY | 10025 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. GREGORY GOIKHBERG | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | |
| Dr. ROBERT GROSS | 6425 LYNCH CANYON DR | LAKE ISABELLA | CA | 93240 | |
| Dr. BINH HUYNH | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. JOSEPH P. CAMERO | 1710 E SAUNDERS ST | LAREDO | TX | 78041 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2017 to Dec 2017 ) |
|---|---|---|---|---|---|
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 138 |
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 134 |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 128 |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. ANN MARIE SWANN | 100 HOSPITAL DR | BENNINGTON | VT | 05201 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. ROBERT GROSS | 6425 LYNCH CANYON DR | LAKE ISABELLA | CA | 93240 | |
| Dr. BINH HUYNH | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. GREGORY GOIKHBERG | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | |
| Dr. MOHAMMAD IQBAL VAKIL | 214 KING ST | OGDENSBURG | NY | 13669 |
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 613,072 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 7,454 | ||||
| DRG Share of Total Hospitalizations | 5.62 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 15.07 | ||||
| Avg LOS at DRG | 6.22 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 7.28 | ||||
| Readmission Rate at DRG | 24.07 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 24.34 | ||||
| Unplanned Readmission Rate at DRG | 16.7 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 19.96 | ||||
| Total Medicare payments at DRG | $7,124,851,803 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $110,677,942 | ||||
| Total Medicare payment per Day at DRG | $1,870 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,040 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,622 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $14,848 | ||||
| Total Medicare Charges at DRG | $36,341,515,154 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $454,549,051 | ||||
| Avg Charges at DRG | $59,278 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $60,981 | ||||
| Mortality Rate at DRG | 12.04 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 13.82 | ||||
| SNF Discharge Rate at DRG | 27.01 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 29.86 | ||||
| Home Discharge Rate at DRG | 25.82 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 23.1 |
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 124,396 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 1,549 | ||||
| DRG Share of Total Hospitalizations | 1.14 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 3.13 | ||||
| Avg LOS at DRG | 3.81 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 4.24 | ||||
| Readmission Rate at DRG | 16.09 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 16.33 | ||||
| Unplanned Readmission Rate at DRG | 11.06 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 12.52 | ||||
| Total Medicare payments at DRG | $742,890,166 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $13,284,930 | ||||
| Total Medicare payment per Day at DRG | $1,566 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,021 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,972 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $8,576 | ||||
| Total Medicare Charges at DRG | $3,318,273,977 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $45,395,072 | ||||
| Avg Charges at DRG | $26,675 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $29,306 | ||||
| Mortality Rate at DRG | 0.87 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 0.77 | ||||
| SNF Discharge Rate at DRG | 17.07 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 16.01 | ||||
| Home Discharge Rate at DRG | 53.1 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 53.0 |
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 84,363 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 811 | ||||
| DRG Share of Total Hospitalizations | 0.77 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.64 | ||||
| Avg LOS at DRG | 12.98 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 15.69 | ||||
| Readmission Rate at DRG | 37.08 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 37.62 | ||||
| Unplanned Readmission Rate at DRG | 17.65 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 26.85 | ||||
| Total Medicare payments at DRG | $2,914,235,137 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $36,895,633 | ||||
| Total Medicare payment per Day at DRG | $2,661 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,900 | ||||
| Total Medicare payment per Hospitalization at DRG | $34,544 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $45,494 | ||||
| Total Medicare Charges at DRG | $14,052,328,443 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $136,568,450 | ||||
| Avg Charges at DRG | $166,570 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $168,395 | ||||
| Mortality Rate at DRG | 13.79 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 18.62 | ||||
| SNF Discharge Rate at DRG | 31.93 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 43.53 | ||||
| Home Discharge Rate at DRG | 14.9 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 10.85 |
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 32,171 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 617 | ||||
| DRG Share of Total Hospitalizations | 0.29 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.25 | ||||
| Avg LOS at DRG | 14.47 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 16.33 | ||||
| Readmission Rate at DRG | 40.95 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 41.01 | ||||
| Unplanned Readmission Rate at DRG | 18.53 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 34.43 | ||||
| Total Medicare payments at DRG | $1,307,580,261 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $31,508,190 | ||||
| Total Medicare payment per Day at DRG | $2,808 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $3,127 | ||||
| Total Medicare payment per Hospitalization at DRG | $40,645 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $51,067 | ||||
| Total Medicare Charges at DRG | $6,501,951,857 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $114,416,998 | ||||
| Avg Charges at DRG | $202,106 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $185,441 | ||||
| Mortality Rate at DRG | 34.94 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 31.6 | ||||
| SNF Discharge Rate at DRG | 25.68 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 46.68 | ||||
| Home Discharge Rate at DRG | 4.2 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 1.94 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2017 to Dec 2017 ) |
|---|---|---|---|---|---|
| NEW YORK - PRESBYTERIAN/QUEENS | 56-45 MAIN STREET | NEW YORK | NY | 11355 | 3,973 |
| NEWYORK PRESBYTERIAN - WEILL CORNELL MEDICAL CENTER | 525 E 68TH ST | NEW YORK | NY | 10021 | 3,671 |
| MONTEFIORE MEDICAL CENTER | 111 E 210TH ST | BRONX | NY | 10467 | 3,467 |
| CONEY ISLAND HOSPITAL | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | |
| THE UNIVERSITY OF TENNESSEE MEDICAL CENTER | 1924 ALCOA HWY | KNOXVILLE | TN | 37920 | |
| ST. ELIZABETH CAMPUS | 2209 GENESEE ST | UTICA | NY | 13501 | |
| STATEN ISLAND UNIVERSITY HOSPITAL | 475 SEAVIEW AVE | STATEN ISLAND | NY | 10305 | |
| CROUSE HOSPITAL | 736 IRVING AVE | SYRACUSE | NY | 13210 | |
| ST. JOSEPH HOSPITAL | 4295 HEMPSTEAD TPKE | BETHPAGE | NY | 11714 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2017 to Dec 2017 ) |
|---|---|---|---|---|---|
| Dr. DAVID M ROGERS | 5645 MAIN ST | FLUSHING | NY | 11355 | 267 |
| Dr. GREGORY GOIKHBERG | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | 193 |
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 189 |
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. ROBERT GROSS | 6425 LYNCH CANYON DR | LAKE ISABELLA | CA | 93240 | |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. FELIKS CHECHELNIKER | 312 NEPTUNE AVE | BROOKLYN | NY | 11235 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. SEEMA J PATEL | 7846 PARSONS BLVD | FLUSHING | NY | 11366 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2017 to Dec 2017 ) |
|---|---|---|---|---|---|
| Dr. GREGORY GOIKHBERG | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | 247 |
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 203 |
| Dr. ANN MARIE SWANN | 100 HOSPITAL DR | BENNINGTON | VT | 05201 | 201 |
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. SEEMA J PATEL | 7846 PARSONS BLVD | FLUSHING | NY | 11366 | |
| Dr. WILLIAM R TOCK | 100 HOSPITAL DR | BENNINGTON | VT | 05201 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. TIEN-TSAI TSAI | 41 MOTT ST | NEW YORK | NY | 10013 |